nav-left cat-right
cat-right

11th Protein Kinases in Drug Discovery Conference ...

We invite you to attend the 11th Protein Kinases in Drug Discovery Conference, which will take place February 29 – March 1, 2016 in San Diego, CA. Over the past decades, protein kinases have proven to be an important class of drug targets for the pharmaceutical industry. This meeting seeks to create a forum for scientists from both industry and academia to gather and discuss the most recent advances in kinase inhibitor...

6th Ubiquitin Research & Drug Discovery Confe...

We are pleased to invite you to GTCbio’s 6th Ubiquitin Research & Drug Discovery Conference, which will take place February 29 – March 1, 2016 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with...

FLEXYTE® assays harness the power and potential of...

Melbourn, UK and Craigavon, Northern Ireland, UK (5th February 2015) – A strategic alliance has been formed for the marketing and sale of a complete fluorescence lifetime (FLT) technology comprising Almac Group’s proprietary FLEXYTE® FLT reagents and assays, and TTP Labtech’s new ameon® microplate reader. Customers can now gain full access to support, and buy equipment and essential reagents all from TTP Labtech,...

XL-protein Signs Licensing Agreement with MSD Anim...

FREISING, GERMANY, February 12, 2015 – XL-protein GmbH, Germany, a privately owned biopharmaceutical company, announced today that they have entered into a license agreement with MSD Animal Health (known as Merck Animal Health in the USA and Canada) to develop PASylated biopharmaceuticals for use in animal health. This license agreement follows a research collaboration between the two companies which began in 2012 and...

Zedira receives further funding to develop Factor ...

Zedira has received further funding from the German Federal Ministry for Education and Research (German abbreviation: BMBF). The project volume has been extended by € 1.0 Mio. so that the total project value exceeds € 5.0 Mio. by now. The additional funding will allow completing the development of a drug candidate for „safe“ anticoagulation. Zedira targets coagulation factor XIIIa (F13, plasma transglutaminase) using...

Polypropylene PCR plates from Porvair Sciences Ltd

To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling. Produced in Class 10,000 clean room conditions – Porvair range of PCR plates are certified free of pyrogens as well as DNAse and RNAse enzyme activity enabling routine achievement of excellent PCR results. Porvair PCR plates are...
Page 4 of 147« First...23456...102030...Last »